OPTIMIZERx is trading at $8.27 (+5.15%) after September 2, 2026 news that former Johnson & Johnson executive Troy Sarich joined its advisory board.

  • The appointment adds nearly 30 years of healthcare, pharmaceutical commercialization, data, analytics, and AI experience.
  • OptimizeRx said the role aims to accelerate innovation and strengthen life-sciences marketing technology.
  • No volume data was available.